Dr. Chekwube Andrew Ezegbe - NANOSCIENCE AND ADVANCED MATERIALS - Best Researcher Award

FEDERAL UNIVERSITY OF ABC - Nigeria

AUTHOR PROFILE

🧪 EARLY ACADEMIC PURSUITS

Ezegbe Chekwube Andrew’s academic journey is marked by a solid foundation in multidisciplinary sciences. He earned a Bachelor of Science in Microbiology and Biochemistry from the University of Nigeria, Nsukka, in 2010. Driven by his passion for health and innovation, he pursued a Bachelor of Pharmacy (B.Pharm) in 2016 from the same institution. Combining his expertise in both microbiology and pharmaceutical sciences, he exemplified a commitment to expanding his academic horizons.

🎓 PROFESSIONAL ENDEAVORS

A licensed pharmacist and dedicated educator, Ezegbe has over six years of teaching experience at a reputable university in Nigeria. His role as a lecturer allowed him to impart knowledge in pharmaceutical technology and industrial pharmacy. Alongside teaching, he actively participated in academic advisory roles, contributing to curriculum development and student mentorship. His expertise in creating collaborative and interactive learning environments has shaped the next generation of professionals.

🌍 CONTRIBUTIONS AND RESEARCH FOCUS

Ezegbe’s research spans pharmaceutical technology, nanoscience, and microbiology. His Master’s thesis explored innovative pharmaceutical technologies, earning him a stellar CGPA of 4.9. NANOSCIENCE AND ADVANCED MATERIALS Currently, he is pursuing a Ph.D. in Nanoscience and Advanced Materials at the Federal University of ABC, Brazil, supported by a prestigious full scholarship. His research focuses on the intersection of advanced materials and pharmaceutical applications, contributing to cutting-edge developments in nanotechnology.

🏆 ACCOLADES AND RECOGNITION

Ezegbe has received notable recognition for his academic and professional excellence. Winning the Federal University of ABC full scholarship for a Ph.D. program in Nanoscience and Advanced NANOSCIENCE AND ADVANCED MATERIALS Materials stands as a testament to his exceptional academic capabilities. His achievements reflect his dedication and pioneering efforts in his field.

🌟 IMPACT AND INFLUENCE

Throughout his career, Ezegbe has significantly impacted the academic and healthcare sectors. His dual expertise in microbiology and pharmacy enables him to address complex challenges in NANOSCIENCE AND ADVANCED MATERIALS public health and pharmaceutical sciences. By integrating nanotechnology into healthcare research, he is paving the way for innovative solutions to pressing global issues.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Ezegbe’s academic and professional journey underscores his commitment to excellence and innovation. As he delves deeper into nanoscience and advanced materials, he is poised to leave a lasting impact on pharmaceutical technology and healthcare research. His legacy lies in bridging disciplines to create transformative solutions for society.

NOTABLE PUBLICATIONS

Title: Evaluation of Metronidazole Tablets Formulated with Different Disintegrants Using Moisture Activated Dry Granulation
Authors: Ezegbe Chekwube Andrew, Ezegbe Amarachi Grace, Chime Amarachi Salome, Ugwu Calister Elochukwu, Boniface Christian Izuchukwu, Ugwuoke Kenneth Ejiofor, Chukwuemeka Chizoba Lorrita, Onunkwo Godswill
Journal: Universal Journal of Pharmaceutical Research
Title: Identification of Cholisterase Inhibitors and Antioxidant Molecules from Leaves of Chlorodendrum Splendes Using GC-MS
Author: Ezegbe C. A.
Journal: Tropical Journal of Natural Product Research
Title: Evaluation of Oro-Dispersible Tablets (Artemether-Lumefantrine and Amoxicillin Trihydrate) Used for Some Common Childhood Diseases (Malaria and Pneumonia)
Authors: Ezegbe Chekwube Andrew, Ezegbe Amarachi Grace, Boniface Christian Izuchukwu, Okorafor Ezinne Chinemerem, Godswill Onunkwo
Journal: Universal Journal of Pharmaceutical Research
Title: Drug Carriers
Author: Ezegbe C. A.
Journal: Journal of Current Biomedical Research
Title: Development and Characterization of Lecithin-Based Nanoformulation for Enhanced Delivery of Isoniazid in the Treatment of Tuberculosis
Author: Ezegbe C. A.
Journal: Indo American Journal of Pharmaceutical Sciences

Early Academic Pursuits

Dr. Ananda Kumar Chettupalli embarked on his academic journey with a strong focus on pharmaceutical sciences, culminating in a Ph.D. under the guidance of Dr. Kunduri Rajeswar Dutt. His early academic pursuits laid the foundation for his extensive career in academics and research, emphasizing advanced nanotechnology formulations, statistical modeling for drug design, and core pharmacokinetic studies.

Professional Endeavors

Dr. Chettupalli has accumulated over 12.6 years of professional experience in academia and research: During his tenure, he has made significant contributions to the field, publishing 35 articles in reputed national and international journals. He has also secured several patents, including grants from Australia and Germany, demonstrating his innovative research contributions in novel drug delivery systems and pharmaceutical technology.

Contributions and Research Focus

Dr. Chettupalli's research interests are centered on developing novel and targeted drug delivery systems: He specializes in Ethosomes, Liposomes, Niosomes, Phytosomes, Spanlastics, Microspheres, Solid lipid nanocarriers, Nanostructured lipid carriers, and Polyherbal drug Nanotechnology formulations.His expertise extends to conducting Phytochemical studies, in-silico evaluations, and both in-vitro and in-vivo assays, enhancing the efficacy and safety profiles of pharmaceutical formulations.

Impact and Influence

Dr. Chettupalli's influence spans academia and industry, evident from his collaborations with governmental agencies for project funding and industry interactions. His research outputs and mentorship have contributed to the development of cutting-edge pharmaceutical technologies Nanotechnology and methodologies.

Legacy and Future Contributions

Dr. Chettupalli's commitment to learning and growth, coupled with his positive attitude and perseverance, positions him to make significant future contributions. His ongoing research in novel drug delivery systems and continued mentorship of doctoral and master's students will likely leave a lasting impact on the pharmaceutical sciences community, fostering innovation and academic excellence.